
Alflüwid H Tablets, 100 count
ALFLÜWID H Tabletten
Manufacturers: Homöopathisches Laboratorium Alexander Pflüger GmbH & Co. KG
PZN: 04570125
Dosage: Tabletten
Content: 100 St
Reward Points: 109
Availability: In stock
$18.39
from German pharmacies to your address

Instructions for use for Alflüwid H Tablets, 100 count
Composition and properties
Alflüwid H tablets contain a careful selection of active ingredients, including Arnica montana Urt. 15.0 mg, Aurum iodatum Trit.D4 15.0 mg, Calcium phosphoricum Trit.D2 30.0 mg, Crataegus Urt. 30.0 mg, Magnesium phosphoricum Trit.D2 30.0 mg and Panax ginseng Urt. 15.0 mg.The other ingredients include calcium behenate (DAB), potato starch and lactose monohydrate.This product is a registered homeopathic medicine and is offered without specifying a therapeutic indication.
Application and dosage
Alflüwid H tablets are suitable for use from the age of 12.In acute conditions, it is recommended to take one tablet every half to an hour, but no more than six times a day.Use beyond one week should only be carried out after consultation with a homeopathically experienced therapist.In chronic forms, the intake can be reduced to one to three tablets per day.As the symptoms improve, the frequency of use should be gradually reduced.
Special Notes
No prescription is required for this product.It is gluten-free, alcohol-free, pork-free and vegetarian.Alflüwid H tablets contain lactose, so people with lactose intolerance should take this into account.There are no known side effects and the product is free of side effects and interactions.
Contraindications
A contraindication is hypersensitivity to arnica and other composite plants.If in doubt, you should consult a doctor or alternative practitioner before use.
Manufacturer information
The Homeopathic Laboratory Alexander Pflüger GmbH & Co. KG , located at Röntgenstr.4, 33378 Rheda-Wiedenbrück, produces Alflüwid H tablets.For further information you can contact the manufacturer directly.
Medicines Reviews
There are no reviews for this product.








